AI Scans 400,000 Reddit Posts, Uncovers Hidden GLP-1 Side Effects: Menstrual Changes, Chills, Fatigue

A peer-reviewed study published in Nature Health on May 24, 2026, by researchers at the University of Pennsylvania School of Engineering and Applied Science, has demonstrated that large language models (LLMs) can turn social media into a powerful, real-time early-warning system for detecting drug side effects that clinical trials often miss. By analyzing over 400,000 Reddit posts written by 67,008 self-reported users of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) over a span of five years, the research team identified several underreported symptoms that warrant closer clinical investigation.

Key Findings and Underreported Side Effects

• Menstrual Irregularities: Nearly 4% of the Reddit users who reported any side effects described reproductive symptoms, including irregular menstrual cycles, intermenstrual bleeding, and unusually heavy bleeding. Researchers noted that this signal would be significantly higher if calculated using a female-only denominator.
• Body Temperature Fluctuations: Users frequently discussed temperature-related symptoms, including chills, feeling cold, hot flashes, and fever-like sensations.
• Unexplained Fatigue: Fatigue emerged as the second most common symptom reported by Reddit users, representing a much higher prominence in real-world patient discussions than what was highlighted in pivotal clinical trials.
• Gastrointestinal Dominance: Consistent with clinical trials, gastrointestinal issues remained the most widely discussed side effect, with 44% of the analyzed users mentioning at least one GI-related symptom.

Clinical and Biological Explanations

Co-author Jena Shaw Tronieri, PhD, a Senior Research Investigator at Penn's Center for Weight and Eating Disorders, pointed out that these temperature and menstrual symptoms are biologically plausible:

"These drugs are thought to work by engaging part of the brain called the hypothalamus, which helps regulate a wide variety of hormones. That doesn't mean the medications are necessarily causing these symptoms, but it could suggest that reports of menstrual changes and body temperature fluctuations are worth studying more systematically."

Methodology: Standardizing Social Media with AI

Historically, mining social media for drug safety was hindered by the informal and varied ways patients describe symptoms. The Penn study overcame this by using LLMs (like GPT and Gemini) to map casual patient descriptions to standardized medical terms from the Medical Dictionary for Regulatory Activities (MedDRA).

Senior author Sharath Chandra Guntuku, PhD, emphasized the value of this speed:

"Clinical trials are the gold standard, but by design, they are slow. This is not a replacement for trials, but it can move much faster, and that speed matters when a drug goes from niche to mainstream almost overnight."

Current Regulatory and Manufacturer Response

As of May 28, 2026, neither the FDA nor the EMA has issued formal label updates or post-marketing requirements specifically in response to this study. The study authors emphasize that while the data shows a strong, unprompted patient signal, it does not prove direct causality. However, the study has successfully established a new paradigm in digital pharmacovigilance, and researchers are currently planning to expand the analysis beyond Reddit and English-speaking communities to see if these patterns hold globally.